Cell Therapy Bioprocessing Originally delivered Feb 8, 2011 Developed by: SBE - Society for Biological Engineering Type: Archived WebinarLevel: Intermediate Duration: 1 hour PDHs: 1.00 Share This Post: Preview Webinar: As cellular therapies are advancing through clinical development and getting closer to market, close collaborations between stem cell biologists, clinical cell processing technologists, and bioengineers will be required for effective commercialization of this new class of drugs. New cell production strategies and technologies will be needed to supply sufficient quantities of cells, of pre-defined quality and biological functionality, and at reasonable costs as these new products come to market. Just as protein therapeutics went through a technology transformation during the 1990’s, cell therapy bioprocessing technologies will go through a similar standardization and scalability evolution over the next 5-15 years. This Webinar will outline many of the challenges and opportunities that lie before the Cell Therapy industry as it transforms from a niche market industry to blockbuster drug status, with a real-world example of a cell therapy drug in mid-stage clinical development. Please join us as this new industry evolves, and as the technical discipline of Cell Therapy Bioprocesing is emerging. Presenter(s): Dr. Robert Deans Read more Dr. Jon Rowley Read more Dr. Peter Zandstra Read more Once the content has been viewed and you have attested to it, you will be able to download and print a certificate for PDH credits. If you have already viewed this content, please click here to login. Checkout Checkout Do you already own this? Log In for instructions on accessing this content. Pricing AIChE Members $69.00 AIChE Undergraduate Student Members Free AIChE Graduate Student Members Free SBE Members Free Non-Members $99.00 Webinar content is available with the kind permission of the author(s) solely for the purpose of furthering AIChE’s mission to educate, inform and improve the practice of professional chemical engineering. All other uses are forbidden without the express consent of the author(s).